Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Getinge AB's gross profit for the
three
months ended in Jun. 2026 was €403 Mil. Getinge AB's gross profit for the trailing twelve months (TTM) ended in Jun. 2026 was €1,526 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Getinge AB's gross profit for the
three
months ended in Jun. 2026 was €403 Mil. Getinge AB's Revenue for the
three
months ended in Jun. 2026 was €765 Mil. Therefore, Getinge AB's Gross Margin % for the quarter that ended in Jun. 2026 was 52.69%.
Getinge AB had a gross margin of 52.69% for the quarter that ended in Jun. 2026 => Durable competitive advantage
During the past 13 years, the highestGross Margin % of Getinge AB was 50.21%. The lowest was 45.54%. And the median was 47.15%.
Warning Sign:
Getinge AB gross margin has been in long-term decline. The average rate of decline per year is -1.3%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Getinge AB had a gross margin of 52.69% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Getinge AB Gross Profit Related Terms
Getinge AB Gross Profit Historical Data
* Premium members only.
The historical data trend for Getinge AB's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1GETI vs ABT, SYK, MDT: Gross Profit Comparison
For the Medical Devices subindustry, Getinge AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Getinge AB Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Gross Profit distribution charts can be found below:
* The bar in red indicates where Getinge AB's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,526 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Getinge AB (MIL:1GETI) has a Gross Profit of €1,526 Mil as of Jun. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Getinge AB and its competitors.
Is Getinge AB's Gross Profit too high?
Getinge AB's current Gross Profit is €1,526 Mil. Overall, Getinge AB has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Getinge AB's Gross Profit compare to ABT and SYK?
Getinge AB's Gross Profit of €1,526 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Getinge AB and its competitors. Getinge AB's current Gross Profit is €1,526 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getinge AB stock overvalued right now?
Based on GuruFocus' analysis, Getinge AB (MIL:1GETI) is currently considered Modestly Overvalued. The stock's GF Value™ is €17.80, compared to a current price of €20.90 — trading 17.4% above its estimated fair value. The current Gross Profit is €1,526 Mil. Getinge AB's overall GF Score™ is 51/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Getinge AB (MIL:1GETI), the current Gross Profit is €1,526 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Getinge AB (MIL:1GETI) Overvalued in 2026?
Based on GuruFocus' analysis, Getinge AB stock appears to be overvalued.
The current stock price of €20.90 is trading 17.4% above its estimated GF Value™ of €17.80.
GuruFocus considers Getinge AB to be Modestly Overvalued.
Key valuation signals for MIL:1GETI:
Gross Profit: €1,526 Mil
GF Value™: €17.80 vs. price of €20.90 (17.4% above fair value)
No single metric tells the full story. See the MIL:1GETI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
51GF Score
Get the complete analysis for MIL:1GETI
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1GETI has been successfully added to your 
